Seqens is a leading global player in pharmaceutical solutions and specialty ingredients.

With operations spanning nine countries, 16 production sites, and nine R&D centres, Seqens employs over 3,300 individuals, including more than 300 scientists, experts, and engineers. The company serves over 1,500 customers across more than 80 countries, generating annual revenues of €1.1 billion.

Key Products and Services:

• Pharmaceutical Ingredients: Manufacturing a broad range of ingredients for the pharmaceutical industry, including generic and custom APIs, intermediates, and excipients.
• Personal Care Ingredients: Producing a wide array of ingredients tailored for the personal care market.
• Custom Specialties: Developing custom specialty ingredients and manufacturing high-quality specialised chemical products.

Seqens is committed to sustainability, integrating social and environmental considerations into its operations and stakeholder relationships. As a global leader, the company prioritises corporate social responsibility, striving to make a positive impact on the environment and communities it serves.